Latham & Watkins advised CyberArk on the transaction, and Kirkland & Ellis advised Thoma Bravo and its portfolio company Venafi. CyberArk (NASDAQ: CYBR), global leader in...
Latham & Watkins advised CyberArk on the transaction, and Kirkland & Ellis advised Thoma Bravo and its portfolio company Venafi. CyberArk (NASDAQ: CYBR), global leader in...
You must be a Standard 1 Year member to access this content.